Theravance Bio: 2Q Earnings Snapshot
GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Thursday reported a loss of $62.9 million in its second quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.
The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
The biopharmaceutical company posted revenue of $15 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $21.1 million.
Theravance Bio shares have dropped 20% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $20.84, an increase of 7% in the last 12 months.